AR013161A1 - Descarboniletoxiloratadina que comprende el polimorfo cristalino forma 1 del mismo esencialmente libre del polimorfo forma 2 y composicion farmaceuticaque la comprende - Google Patents

Descarboniletoxiloratadina que comprende el polimorfo cristalino forma 1 del mismo esencialmente libre del polimorfo forma 2 y composicion farmaceuticaque la comprende

Info

Publication number
AR013161A1
AR013161A1 ARP980103203A ARP980103203A AR013161A1 AR 013161 A1 AR013161 A1 AR 013161A1 AR P980103203 A ARP980103203 A AR P980103203A AR P980103203 A ARP980103203 A AR P980103203A AR 013161 A1 AR013161 A1 AR 013161A1
Authority
AR
Argentina
Prior art keywords
polymorph form
pharmaceutical composition
essentially free
decarbonyletoxylloratadine
decarbonylethoxyloratadine
Prior art date
Application number
ARP980103203A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25389724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR013161(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR013161A1 publication Critical patent/AR013161A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Descarboniletoxiloratadina, que comprende el polimorfo cristalino forma 1 de descarboniletoxiloratadina esencialmente libre de polimorfo forma 2, quecomprende además el siguiente patron de difraccion de polvo de rayos X que tiene picoscaracte rísticos expresados en términos de espacio d eintensidades relativas (IR) a aproximadamente: espacio d(+/- 0,04) son: 9,04, 6,42, 5,67, 5,02, 3,58 son todos IR débil y composicion farmacéuticaque la comprende utiles para tratarreacciones alérgic as en mamífero Por descarboniletoxiloratadina se entiende 3-cloro-6,11-dihidro-11-(4-piperidilideno)-5H-benzo[5.6]ciclohepta[1,2.b]piridina.
ARP980103203A 1997-07-02 1998-07-01 Descarboniletoxiloratadina que comprende el polimorfo cristalino forma 1 del mismo esencialmente libre del polimorfo forma 2 y composicion farmaceuticaque la comprende AR013161A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88676697A 1997-07-02 1997-07-02

Publications (1)

Publication Number Publication Date
AR013161A1 true AR013161A1 (es) 2000-12-13

Family

ID=25389724

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103203A AR013161A1 (es) 1997-07-02 1998-07-01 Descarboniletoxiloratadina que comprende el polimorfo cristalino forma 1 del mismo esencialmente libre del polimorfo forma 2 y composicion farmaceuticaque la comprende

Country Status (26)

Country Link
EP (1) EP0993455B1 (es)
JP (2) JP2002507991A (es)
KR (1) KR20010014316A (es)
CN (1) CN1261886A (es)
AR (1) AR013161A1 (es)
AT (1) ATE239010T1 (es)
AU (1) AU734487B2 (es)
BR (1) BR9811658A (es)
CA (1) CA2294352C (es)
CO (1) CO4940423A1 (es)
DE (1) DE69814076T2 (es)
ES (1) ES2197480T3 (es)
HK (1) HK1024687A1 (es)
HU (1) HUP0004308A3 (es)
IL (1) IL133387A (es)
MY (1) MY132943A (es)
NO (1) NO996547L (es)
NZ (1) NZ501417A (es)
PE (1) PE86399A1 (es)
PL (1) PL337712A1 (es)
RU (1) RU2197485C2 (es)
SK (1) SK185299A3 (es)
TR (1) TR199903308T2 (es)
UA (1) UA62976C2 (es)
WO (1) WO1999001450A1 (es)
ZA (1) ZA985783B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
AU2003262141A1 (en) * 2002-04-15 2003-10-27 Sun Pharmaceutical Industries Limited Preperation of desloratatine
AU2003251974C1 (en) * 2002-08-05 2006-09-14 Sandoz Ag Novel salt and polymorphs of desloratadine hemifumarate
US20040229896A1 (en) * 2003-03-12 2004-11-18 Toth Zoltan G. Stable pharmaceutical compositions of desloratadine
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
WO2006003479A2 (en) * 2004-07-07 2006-01-12 EGIS Gyógyszergyár Rt. New pseudopolymorph of desloratadine formed with carbon dioxide
CA2641668A1 (en) * 2005-11-17 2008-05-15 Teva Pharmaceutical Industries Ltd. Desloratadine crystalline forms mixtures having a low level of residual solvents
HU230417B1 (hu) * 2006-10-26 2016-05-30 Egis Gyógyszergyár Zrt Eljárás desloratadine szén-dioxiddal képezett adduktjának előállítására
CA2687019A1 (en) * 2007-05-11 2008-11-20 Ratiopharm Gmbh Pharmaceutical composition comprising desloratadine
EP2269586B1 (en) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising desloratadine
WO2011141483A2 (en) 2010-05-10 2011-11-17 Laboratorios Lesvi, S.L. Stable pharmaceutical formulations containing an antihistaminic
EP2727592A1 (en) 2012-11-05 2014-05-07 Kücükgüzel, Sükriye Güniz A combination of desloratadine and paracetamol
CN103755682A (zh) * 2013-12-30 2014-04-30 山东达因海洋生物制药股份有限公司 一种地氯雷他定新晶型及制备方法
CN108358892A (zh) * 2018-04-11 2018-08-03 常州方圆制药有限公司 一种地氯雷他定粗品的提纯方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DE3677842D1 (de) * 1985-05-13 1991-04-11 Schering Corp Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.

Also Published As

Publication number Publication date
PL337712A1 (en) 2000-08-28
MY132943A (en) 2007-10-31
HUP0004308A2 (hu) 2001-10-28
KR20010014316A (ko) 2001-02-26
RU2197485C2 (ru) 2003-01-27
CN1261886A (zh) 2000-08-02
HUP0004308A3 (en) 2004-07-28
SK185299A3 (en) 2000-07-11
IL133387A (en) 2004-02-08
CO4940423A1 (es) 2000-07-24
IL133387A0 (en) 2001-04-30
JP2009242436A (ja) 2009-10-22
AU8271098A (en) 1999-01-25
AU734487B2 (en) 2001-06-14
CA2294352C (en) 2008-05-06
HK1024687A1 (en) 2000-10-20
DE69814076T2 (de) 2004-02-26
EP0993455B1 (en) 2003-05-02
WO1999001450A1 (en) 1999-01-14
CA2294352A1 (en) 1999-01-14
DE69814076D1 (de) 2003-06-05
NO996547L (no) 2000-03-01
TR199903308T2 (xx) 2000-11-21
NO996547D0 (no) 1999-12-29
ATE239010T1 (de) 2003-05-15
BR9811658A (pt) 2000-09-05
ES2197480T3 (es) 2004-01-01
UA62976C2 (en) 2004-01-15
EP0993455A1 (en) 2000-04-19
JP2002507991A (ja) 2002-03-12
NZ501417A (en) 2000-10-27
ZA985783B (en) 1999-01-19
PE86399A1 (es) 1999-10-23

Similar Documents

Publication Publication Date Title
AR013161A1 (es) Descarboniletoxiloratadina que comprende el polimorfo cristalino forma 1 del mismo esencialmente libre del polimorfo forma 2 y composicion farmaceuticaque la comprende
DE69943287D1 (de) Antibiotische zusammensetzung, die moxifloxacin enthält, zur behandlung von augen
DE60005560D1 (de) Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems
DE60100851D1 (de) Piperidin verbindung zur behandlung von psoriasis
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
IS5462A (is) Setin 4-amínó-þíazol-2-yl efnasambönd sem hindrarfyrir CDK
ATE239011T1 (de) Neuartige form von s-omeprazol
ATE253361T1 (de) Mittel zur gesteuerten freisetzung von paroxetin
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
BR0109109A (pt) Composto, uso do mesmo, processo para prepará-lo, composição farmacêutica, e, método de tratar um estado doentio mediado por ccr5 em mamìferos
ATE304530T1 (de) Substituierte 1,5-dihydropyrrol-2-on-derivate wirksam als nmda-rezeptor-antagonisten für die behandlung von schmerzzuständen
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
NO996287L (no) Chalkoner med antiproliferativ aktivitet
BR9607335A (pt) Compostos 1-aril-2-acrilamino-etano e seu uso como neuroquinina especialmente antogonistas de neuroquinina 1
BR9605759A (pt) Processo contínuo para preparação de 4-mino-2,2,6,6-tetrametilpiperidina
PT1073438E (pt) Composicoes orais de 8-cloro-6,11-dihidro-11-(4-piperidilidina)-5h-benzo¬5,6|ciclohepta¬1,2-b|piridina
DE60001255T2 (de) Zusammensetzung zur Behandlung von Polyesterfaser
ITMI942103A0 (it) Procedimento pecologico per la formazione di bottoni di abbigliamento
PT955289E (pt) Processo para o tratamento de materiais texteis
IS4783A (is) 1,4 -Díhýdrópýridín efnasambönd sem mótlyf gegn kínínseinkun
NO20004583D0 (no) Krystallinsk form av paroxetine
BR9701631A (pt) Processo de adição de elementos halogênios à compostos terras-raras/metais de transição-3d por difusão controlada
ITMI920720A1 (it) Forma cristallina dell'endo-3-etil-2, 3-diidro-n-(8-metil-8-azabiciclo (3. 2. 1) ott-3-il)- 2-oxo-1h-benzimidazolo-1-carbossamide cloridrato
ITAR990001A0 (it) Dispositivo a slitta e fermo per la regolazione dell'ampiezza di articoli ornamentali e per la loro commutazione

Legal Events

Date Code Title Description
FB Suspension of granting procedure